Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R9RK
|
|||
| Drug Name |
PMID27109571-Compound-23
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H26N6
|
|||
| Canonical SMILES |
CC1CCC2=C(C1)C(=C(C(=N2)C3CCCC3)C4=NNN=N4)C5=CC(=NC=C5)C
|
|||
| InChI |
1S/C22H26N6/c1-13-7-8-18-17(11-13)19(16-9-10-23-14(2)12-16)20(22-25-27-28-26-22)21(24-18)15-5-3-4-6-15/h9-10,12-13,15H,3-8,11H2,1-2H3,(H,25,26,27,28)
|
|||
| InChIKey |
LSPFDXQDUWKIKF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
| Fatty acid-binding protein 5 (FABP5) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Fatty acid-binding protein 4 (FABP4) | Target's Patent Info | [1] | |
| Fatty acid-binding protein 5 (FABP5) | Target's Patent Info | [1] | ||
| KEGG Pathway | PPAR signaling pathway | |||
| NetPath Pathway | IL1 Signaling Pathway | |||
| TCR Signaling Pathway | ||||
| Pathway Interaction Database | AP-1 transcription factor network | |||
| Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
| Transcriptional regulation of white adipocyte differentiation | ||||
| WikiPathways | Lipid digestion, mobilization, and transport | |||
| Transcriptional Regulation of White Adipocyte Differentiation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.